Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biostar Pharmaceuticals Inc

BSPM
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US0906783016
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange PINK
Capitalization 316 463 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
BSPM
21.11.2021 - 28.11.2021

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China. Address: No. 588 Shiji Xi Road, Xianyang, China, 712000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7 USD

P/E ratio

Dividend Yield

Current Year

+2 384 492 USD

Last Year

+27 129 609 USD

Current Quarter

Last Quarter

Current Year

+915 174 USD

Last Year

+11 104 065 USD

Current Quarter

Last Quarter

Key Figures BSPM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 3 894 331 USD
Operating Margin TTM 876.46 %
PE Ratio
Return On Assets TTM 4.25 %
PEG Ratio
Return On Equity TTM 2.66 %
Wall Street Target Price 7 USD
Revenue TTM 317 794 USD
Book Value 13.71 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 915 174 USD
Earnings per share
Diluted Eps TTM
Most Recent Quarter III 2017
Quarterly Earnings Growth YOY
Profit Margin 294.01 %

Dividend Analytics BSPM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BSPM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:7
Payout Ratio
Last Split Date 05.02.2016
Dividend Date

Stock Valuation BSPM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.9958
Price Sales TTM 0.9958
Enterprise Value EBITDA 0.0646
Price Book MRQ 0.0088

Financials BSPM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BSPM

For 52 weeks

0.0001 USD
50 Day MA 0.0001 USD
Shares Short Prior Month 246 695
200 Day MA 0.0001 USD
Short Ratio 3
Shares Short 170 439
Short Percent 7.74 %